Ironwood Pharmaceuticals Inc (NASDAQ:IRWD)
| 12.67 Delayed Data As of 5:22pm ET |  +0.315 / +2.55%Today’s Change | 8.63 Today|||52-Week Range 14.27 | +11.19% Year-to-Date |
Latest IRWD News | Press Releases
| Roche (RHHBY) Lung Cancer Drug Gets Positive CHMP Opinion Sep 20 / Zacks.com - Paid Partner Content | Horizon (HZNP) Begins Phase IV Study on Tepezza for Chronic TED Sep 08 / Zacks.com - Paid Partner Content |
| Aerie (AERI) Announces Mixed Data From Dry Eye Disease Study Sep 16 / Zacks.com - Paid Partner Content | RedHill's (RDHL) Opaganib Effective Against Kidney Fibrosis Sep 08 / Zacks.com - Paid Partner Content |
| Citius (CTXR) Acquires Dr. Reddy's License for NHL Therapy Sep 08 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 12.35 |
| Today’s open | 12.44 |
| Day’s range | 12.41 - 12.95 |
| Volume | 61,450 |
| Average volume (3 months) | 1,862,105 |
| Market cap | $2.0B |
Data as of 5:22pm ET, 09/21/2021
Growth & Valuation
| Earnings growth (last year) | +383.31% |
| Earnings growth (this year) | +263.23% |
| Earnings growth (next 5 years) | +7.00% |
| Revenue growth (last year) | -9.08% |
| P/E ratio | 4.1 |
| Price/Sales | 4.70 |
| Price/Book | 31.69 |
Financials
| Next reporting date | November 4, 2021 |
| EPS forecast (this quarter) | $0.25 |
| Annual revenue (last year) | $389.5M |
| Annual profit (last year) | $106.2M |
| Net profit margin | 27.26% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
